Trial · NCT05887843
Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis
NCT05887843, Phase 1, Terminated, Sandoz
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis. Trials, record NCT05887843. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05887843
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis
- NCT number
- NCT05887843
- Status
- Terminated
- Phases
- Phase 1
- Enrollment
- 38 participants, actual
- Lead sponsor
- Sandoz
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Mometasone + Azelastine, Mometasone Furoate, Azelastine Hydrochloride
- First posted
- 2023-06-05
- Last updated
- 2023-09-28
- Other registries' IDs
- eudract:2023-000362-34
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | AUCt | From time 0 hours (prior to dosing), up to 48 or 72 hours post dose | The area under the analyte concentration versus time curve, from time zero (0) to the time of the last measurable analyte concentration (t), as calculated by the linear up/log down variant of the trapezoidal method. |
| Primary | AUCinf | From time 0 hours (prior to dosing), up to 48 or 72 hours post dose | The area under the analyte concentration versus time curve from time zero to infinity. AUCinf = AUCt + Ct/Kel, where Ct is the last measurable analyte concentration. |
| Primary | Cmax | From time 0 hours (prior to dosing), up to 48 or 72 hours post dose | Maximum measured analyte concentration over the sampling period. |
| Primary | Tmax | From time 0 hours (prior to dosing), up to 48 or 72 hours post dose | Time of the maximum measured analyte concentration over the sampling period. |
| Primary | Kel | From time 0 hours (prior to dosing), up to 48 or 72 hours post dose | The apparent first-order elimination rate constant |
| Primary | Thalf | From time 0 hours (prior to dosing), up to 48 or 72 hours post dose | The apparent elimination half-life |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05887843
GET https://conductscience.org/api/trials/v1/NCT05887843/registered